Legal Representation
Attorney
Brandi G. Brenner
USPTO Deadlines
Next Deadline
1077 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-10-18)
Due Date
October 18, 2028
Grace Period Ends
April 18, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 12, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Oct 18, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 18, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 2, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 2, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 13, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 27, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 22, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 22, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 22, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 17, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 25, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 25, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 25, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 25, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 14, 2021 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Oct 12, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Aug 26, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, enzymatic compositions for the treatment and management of gluten intolerance
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005